Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-01 Purchase | 2022-04-05 4:15 pm | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 15,000 | $0.739 | $11,085 | 370,158 (Indirect Direct) | View |
| 2022-04-01 Purchase | 2022-04-04 4:15 pm | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $0.7474 | $7,474 | 52,081 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Disposition | 2024-01-24 5:34 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Secor Alicia Director | 151,000 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:29 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | GERAGHTY JAMES A Director | 195,391 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:27 pm | N/A 2029-01-15 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 2,332,541 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:25 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 163,294 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:20 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Beck Joanne T. Director | 160,294 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:18 pm | N/A 2026-09-13 | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 4,550,438 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:17 pm | N/A 2028-06-11 | Orchard Therapeutics plc | ORTX | Dunoyer Marc Director | 268,209 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:16 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Altschuler Steven Director | 151,000 | $0 | 0 (Direct) | View |
| 2024-01-24 Disposition | 2024-01-24 5:16 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Curnutte John T Director | 151,000 | $0 | 0 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Altschuler Steven Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Curnutte John T Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Dunoyer Marc Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | GERAGHTY JAMES A Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Secor Alicia Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Beck Joanne T. Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:30 pm | N/A 2033-06-13 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 08:30 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0 | 427,081 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 08:30 am | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0.4591 | 427,081 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 6:00 pm | N/A 2033-02-28 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 585,000 | $0 | 585,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 6:00 pm | N/A 2033-02-28 | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 1,145,000 | $0 | 1,145,000 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 08:09 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0 | 427,081 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 08:09 am | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0.4591 | 427,081 (Direct) | View |
| 2022-10-04 Disposition | 2022-10-06 6:11 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 1,398,145 | $0 | 1,930,956 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 6:11 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 1,930,956 | $0 | 1,930,956 (Direct) | View |
| 2022-10-04 Disposition | 2022-10-06 6:11 pm | N/A 2029-01-15 | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 1,455,006 | $0 | 1,455,006 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 6:11 pm | N/A 2029-01-15 | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 1,455,006 | $0 | 1,455,006 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:10 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Secor Alicia Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:06 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Beck Joanne T. Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:06 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | GERAGHTY JAMES A Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:05 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:05 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Dunoyer Marc Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:05 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Altschuler Steven Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:05 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Curnutte John T Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 08:00 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 375,000 | $0 | 375,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 08:00 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | Gaspar Bobby Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:02 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:02 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Secor Alicia Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:02 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Altschuler Steven Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:02 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | GERAGHTY JAMES A Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:01 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Dunoyer Marc Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:01 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Curnutte John T Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:00 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Beck Joanne T. Director | 40,000 | $0 | 40,000 (Direct) | View |